Method for improving volume of production of rifamycin

A high-yield, high-quality technology, applied in the field of increasing the yield of rifamycin, can solve problems such as low success rate, unstable high-yielding strains, and prone to reverse mutations

Inactive Publication Date: 2008-04-02
SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These methods have a large workload, high cost, and low success rate, and the

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for improving volume of production of rifamycin
  • Method for improving volume of production of rifamycin
  • Method for improving volume of production of rifamycin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Example 1: Preparation of DNA probes required for cloning two-component systems

[0048] Among the currently known response regulator proteins, OmpR (Escherichia coli DNA binding protein) is a well-studied bacterial regulatory protein (Parkinson JS and Kofoid EC. Communication modules inbacterial signaling proteins. Annu Rev Genet.1992; 26: 71-112 ), the three-dimensional structure obtained by X-ray crystallography shows that its C-terminus has a very typical α-helix-loop-α-helix DNA binding region. OmpR proteins can enhance the transcription function of RNA polymerase by binding to the promoter region of the gene, so as to regulate the transcription of the corresponding gene. According to the conserved amino acid sequence of OmpR family proteins (GLEVGADD near the N-terminal, TVRGVGY near the C-terminal) (Wray LVJr, Fisher SH. The Streptomyces coelicolor glnR gene encodes a protein similar to other bacterial response regulators. Gene.1993Aug 16; 130 (1):145-50), desig...

Embodiment 2

[0049]Example 2: Screening of amrE and amkE genes from the A. mediterranei U-32 genome library

[0050] Due to the existence of OmpR protein gene in Escherichia coli DH5α (Gibco-BRL), it is difficult to screen the correct positive clones by using bacterial colony in situ hybridization, so the dot DNA hybridization method was used for screening. 46-50 colonies were divided into one group to extract mixed plasmids, and a total of 80 groups of mixed plasmids (equivalent to 3800 recombinant plasmids) were extracted. Using a 96-well dot blot injector, spot the denatured mixed plasmids on a nylon membrane, and then hybridize with the DNA probe prepared in Example 1. Select stringent conditions for washing the membrane, and as a result, 4 positive hybridization points were obtained on the membrane, numbered 2, 20, 21, and 63 (see Figure 1A), and the plasmids of 50 colonies corresponding to No. 63 were extracted for the second round After hybridization screening, the recombinant clon...

Embodiment 3

[0051] Example 3: Sequencing and Analysis of Amycobacterium mediterranei U-32amrE and amkE Gene Sequences

[0052] Plasmid pLR6350 was digested with BglII, StuI, SacI, PstI, XhoI enzymes, electrophoresis, Southern transfer, and hybridized with the DNA probe prepared in Example 1. The results showed that BglII, StuI, SacI, PstI, XhoI enzymes were digested respectively Single hybridization bands of 2.5 kb, 12 kb, 2.0 kb, 1.2 kb and 4.6 kb were generated. The 2.5 kb BglII restriction fragment and the 2.0 kb PstI restriction fragment were respectively cloned into the BamHI and PstI sites of pBlueScriptIIKS vector (Stratagene) to obtain plasmids pKS2.5B and pKS2.0P. The plasmids pKS2.5B and pKS2.0P were sequenced to obtain a DNA sequence of 3238bp (see FIG. 3 ).

[0053] Sequence analysis showed that there were two closely linked complete reading frames (ORFs) on the sequenced 3.2kb DNA fragment. ORF1 starts from ATG at position 456 and ends at TGA at position 1139, with a full l...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a method of controlling the two-component regulatory system of bacteria, in particular to an amrE gene and/or an amkE gene or homologous genes of the amrE gene or the amkE gene, which improves the yield of antibiotics and other useful secondary metabolites.

Description

technical field [0001] The present invention relates to a method for increasing the production of antibiotics and other useful secondary metabolites by controlling the two-component regulatory system of bacteria, especially the amrE and / or amkE genes or their highly homologous genes. In particular, the present invention relates to Amycolatopsis mediterranei and a method for producing rifamycin using the bacteria. Background technique [0002] The two-component regulatory system (two-component systems) is an important signal transduction regulatory system in bacterial cells, which is composed of sensor protein (sensor kinase) and response regulator protein (response regulator) (Parkinson JS and Kofoid EC.Communication modules in bacterial signaling proteins. Annu Rev Genet. 1992;26:71-112). Bacteria first feel the stimulation of external signals. In the presence of ATP, the histidine site of the sensing protein undergoes autophosphorylation, and then transfers the high-energ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N1/21C12P17/18C12N15/31
Inventor 赵国屏王金崔明学丁晓明邵志会王颖姜卫红杨蕴刘杨晟焦瑞身
Owner SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products